Cargando…
Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients
BACKGROUND: The pathogenesis of interstitial cystitis/bladder pain syndrome (IC/BPS) has not been elucidated, but urinary microorganisms and metabolites have been shown to be closely associated with the inflammatory response of IC/BPS. Nevertheless, the exact mechanisms related to this response have...
Autores principales: | Zheng, Zhenming, Hu, Jintao, Li, Wenshuang, Ma, Kaiqun, Zhang, Caixia, Li, Kuiqing, Yao, Yousheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114403/ https://www.ncbi.nlm.nih.gov/pubmed/37076836 http://dx.doi.org/10.1186/s12967-023-04115-5 |
Ejemplares similares
-
Preliminary Exploration of a New Therapy for Interstitial Cystitis/Bladder Pain Syndrome: Botulinum Toxin A Combined with Sapylin
por: Li, Wenshuang, et al.
Publicado: (2022) -
The study on the function and cell source of interleukin‐6 in interstitial cystitis/bladder painful syndrome rat model
por: Zheng, Zhenming, et al.
Publicado: (2021) -
Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer
por: Zheng, Zhenming, et al.
Publicado: (2021) -
Combined Signature of the Urinary Microbiome and Metabolome in Patients With Interstitial Cystitis
por: Xu, Hewei, et al.
Publicado: (2021) -
Interstitial cystitis/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome
por: Bhide, Alka, et al.
Publicado: (2020)